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Moosa Mohammadi,* Joseph Schlessinger,* growth factors such as platelet-derived growth factor
(PDGF) or colony-stimulating factor 1 (CSF1), which areand Stevan R. Hubbard*†
*Department of Pharmacology dimeric molecules, FGFs are monomeric and are unable
by themselves to induce receptor dimerization. Dimer-†Skirball Institute of Biomolecular Medicine
New York University Medical Center ization of FGF receptors is mediated by either soluble
or cell surface-bound heparin sulfate proteoglycans,New York, New York 10016
which in concert with FGFs promote receptor dimeriza-
tion, activation, and induction of biological responses
(reviewed by Schlessinger et al., 1995).Summary
We have shown previously that the cytoplasmic do-
main of FGFR1 (also known as Flg) contains at leastThe crystal structure of the tyrosine kinase domain of
seven tyrosine autophosphorylation sites (Mohammadifibroblast growth factor receptor 1 (FGFR1K) has been
et al., 1992, 1996). Autophosphorylation of Tyr-653 anddetermined in its unliganded form to 2.0 A˚ resolution
Tyr-654, located in the catalytic domain, is critical forand in complex with an ATP analog to 2.3 A˚ resolution.
upregulation of kinase activity. Tyr-766 in the C-terminalSeveral features distinguish the structure of FGFR1K
tail functions upon autophosphorylation as a high affinityfrom that of the tyrosine kinase domain of the insulin
binding site for phospholipase Cg (PLCg), and is essen-receptor. Residues in the activation loop of FGFR1K
tial for FGF-induced stimulation of phosphatidylinositolappear to interfere with substrate peptide binding but
hydrolysis (Mohammadi et al., 1992; Peters et al., 1992).not with ATP binding, revealing a second and perhaps
The biological roles of the other four FGFR1 autopho-more general autoinhibitory mechanism for receptor
sphorylation sites are not yet known.tyrosinekinases. Inaddition, a dimeric form of FGFR1K
Although it is now well established that PTK activityobserved in the crystal structure may provide insights
is stimulated by receptor dimerization, the molecularinto the molecular mechanisms by which FGF recep-
mechanisms by which this occurs are not well under-tors are activated. Finally, the structure provides a
stood. For receptor PTKs such as the insulin and FGFbasis for rationalizing the effects of kinase mutations
receptors, autophosphorylation of tyrosine residues inin FGF receptors that lead to developmental disorders
the catalytic domain is required for stimulation of kinasein nematodes and humans.
activity and biological function (Ellis etal., 1986; Moham-
madi et al., 1996). To begin to elucidate the mechanismsIntroduction
underlying FGF receptor activation, we have determined
the crystal structure of the unphosphorylated, unli-Growth factors play important roles in the control of cell
ganded form of FGFR1K to 2.0 A˚ resolution and thegrowth, differentiation, metabolism, and oncogenesis.
structure of the binary complex of unphosphorylatedTheir diverse biological effects are mediated by a large
FGFR1K with a nonhydrolyzable ATP analog, adenylylfamily of cell surface receptors with intrinsic protein
diphosphonate (AMP–PCP), to 2.3 A˚ resolution. Severaltyrosine kinase (PTK) activity. Binding of a growth factor
features distinguish the FGFR1K structure from that ofto the extracellular domain of its receptor induces recep-
the insulin receptor tyrosine kinase (IRK), the only othertor dimerization, resulting in autophosphorylation of
PTK domain whose three-dimensional structure hasspecific tyrosine residues in the cytoplasmic domain
been reported (Hubbard et al., 1994). These distinctions(reviewed by Ullrich and Schlessinger, 1990).These pho-
are likely to be important in signaling by FGF receptorssphotyrosines either stimulate PTK activity or serve as
and perhaps by other receptor PTKs that undergo li-binding sites for downstream signaling proteins con-
gand-dependent dimerization.taining Src-homology 2 (SH2) or phosphotyrosine-
binding (PTB) domains (reviewed by Cantley et al., 1991;
Pawson and Schlessinger, 1993; Kavanaugh and Wil- Results and Discussion
liams, 1994).
Nine mammalian FGFs have been identified to date Structure Determination
A baculovirus/insect cell system was used to expressand have been shown to be involved in the control of
a variety of biological responses that are crucial for a cytoplasmic fragment of human FGFR1, residues 456–
765, that possesses PTK activity. Cytoplasmic residuesorganismal development and survival (reviewed by Ba-
silico and Moscatelli, 1992). The mammalian FGF recep- of FGFR1 that are not included in the expressed protein
are the first 58 (juxtamembrane) and last 57 (C-terminaltor family comprises at least four different gene prod-
ucts, with additional diversity generated by alternative tail). Crystals belonging to monoclinic space group C2
were obtained of the unphosphorylated, unligandedRNA splicing (reviewed by Jaye et al., 1992). Homologs
of mammalian FGF receptors have been identified in a form of FGFR1K and diffract X-rays to at least 2.0 A˚
Bragg spacings. There are two FGFR1K molecules inwide range of species including Drosophila melanogas-
ter (Klambt et al., 1992) and Caenorhabditis elegans the asymmetric unit, related by an approximate 2-fold
axis. Crystals of FGFR1K complexed with AMP–PCP(DeVore et al., 1995).
As is true for other receptor PTKs, dimerization of FGF were obtained by cocrystallizing protein and ATP
analog.receptors is essential for activation. However, unlike
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Figure 1. Electon Density Maps Near the FGFR1K Active Site
(A) Stereo view of a 2Fo-Fc electron density map computed at 2.0 A˚ resolution and contoured at 1s. Superimposed is the refined atomic model.
Carbon atoms are colored green, oxygen atoms red, and nitrogen atoms blue. The red spheres represent water molecules.
(B) 2Fo-Fc simulated annealing omit map of the AMP-PCP electron density computed at 2.3 A˚ resolution and contoured at 1s. Coloring as in
(A) with phosphorus atoms colored purple. The g-phosphate group is disordered and therefore not shown.
(A) and (B) prepared with SETOR (Evans, 1993).
The crystal structure of unphosphorylated FGFR1K in both FGFR1K molecules. In FGFR1K, aC is longer by
one helical turn than in IRK and is oriented such thatwas determined using a combination of molecular re-
placement and multiple isomorphous replacement (MIR) protein kinase-conserved residues Lys-514 and Glu-531
are in position to form a salt bridge (Figure 4A). Thisphasing techniques (see Experimental Procedures). The
structure has been refined to 2.0 A˚ resolution with a salt bridge, not observed in the unphosphorylated IRK
structure, is thought to be important for proper align-crystallographic R-value of 21.3%. The structure of un-
phosphorylated FGFR1K complexed with AMP–PCP ment of the lysine side chain, which coordinates two
phosphate oxygens of ATP.was determined by difference Fourier methods and has
been refined to 2.3 A˚ resolution with an R-value of A number of receptor and nonreceptor PTKs, includ-
ing the insulin, FGF, and PDGF receptors, Src and Abl,20.0%. Electron density maps in the vicinity of the active
site are shown in Figure 1. Data collection, phasing and contain a WE sequence motif (Trp-471 in FGFR1) 14
residues prior to the first glycine in the nucleotide-refinement statistics are given in Table 1.
binding loop (Gly-485). In theFGFR1K structure, the side
chain of Trp-471 is packed against the side chains ofStructural Features
Leu-547 and Lys-536, and the carboxylate group of Glu-The overall architecture of FGFR1K is bi-lobate (Figure
472 is hydrogen-bonded to Thr-552. For those PTKs2A) like that of IRK and the protein serine/threonine
with a WE motif, either a threonine or serine is found atkinases (PSKs) whose three-dimensional structures
the equivalent position of Thr-552. The WE residueshave been determined (reviewed by Johnson et al.,
evidently provide important structural stabilization in the1996). ATP is coordinated primarily by residues in the
N-terminal lobe and appear to demarcate the boundaryN-terminal lobe and substrate peptide binding and catal-
between the kinase domain and the preceding juxta-ysis are performed by residues in the C-terminal lobe.
membrane region (for receptor PTKs).The N-terminal lobe of FGFR1K comprises a curled b
The cores of the C-terminal lobes of FGFR1K and IRKsheet of five anti-parallel b strands (b1-b5) and one a
are similar. A superposition of the Ca atoms in commonhelix (aC). The C-terminal lobe comprises two b strands
in helices aD-aI gives an rmsd of only 1.0 A˚ (Figure 4B).(b7, b8) and seven a helices (aD, aE, aEF, aF-aI). The
A significant difference is found in the C-terminal helixsecondary structure nomenclature follows that for IRK
of FGFR1K, aI, which is longer by seven residues (two(Hubbard et al., 1994), which in turn is based on the
helical turns) than its counterpart in IRK. The extendedassignments for cyclic AMP-dependent protein kinase
length of aI is presumably important in the biological(cAPK; Knighton et al., 1991). A structure-based se-
functioning of FGF receptors, since the tyrosine auto-quence alignment of FGFR1K and IRK is shown in Fig-
phosphorylation site to which an SH2 domain of PLCgure 3.
binds is six residues C-terminal to this helix (Tyr-766 inThe b-sheet topologies of FGFR1K and IRK are quite
FGFR1; not in the present construct). Proper positioningsimilar, with a root-mean-square deviation (rmsd) of only
of the SH2 domain by phosphorylated Y766 is likely to0.5 A˚ for a superposition of the Ca atoms in common
be important for optimal presentation of the phosphory-in the five b strands (Figure 4A). Significant differences
lation sites of PLCg to the active site of FGFR1.in the N-terminal lobe are found in the loops between
The relative orientation of the N- and C-terminal lobesb strands and in aC. The so-called nucleotide-binding
loop, between b1 and b2, is poorly ordered in one in protein kinase structures shows considerable variabil-
ity (reviewed in Johnson et al., 1996). UnphosphorylatedFGFR1K molecule and disordered (i.e. not included in
the atomic model) in the other FGFR1K molecule in the FGFR1K displays an open disposition of the N- and
C-terminal lobes, characteristic of an inactive kinaseasymmetric unit. The loop between b2 and b3 contains
a two-residue insertion vis-a-vis IRK and is disordered conformation, which is z98 less open than that observed
Structure of the FGFR1 Tyrosine Kinase Domain
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Table 1. Data Collection, MIR Phasing and Refinement Summary
Data Collection
Native AMP-PCP Thi-1a Thi-2a PCMBa KAu(CN)2
X-ray source X-4A RU-200 RU-200 RU-200 RU-200 RU-200
Resolution limit (A˚) 2.0 2.3 2.6 2.8 2.8 2.8
Number of sites — — 4 7 2 2
Conc. (mM)/time (hr) — — 0.1/24 0.1/48 0.2/2 5.0/72
Rsymb (%) 4.8 (19.7)c 4.5 (23.3)c 5.5 9.8 6.8 6.8
Total observations 122569 91324 55456 59488 67988 45303
Unique reflections 50771 31997 42820d 35538d 18619 18202
Completeness (%) 97.3 (96.3)c 95.5 (93.7)c 95.0 96.7 98.0 97.7
Signal (%l . 3s) 80.7 (50.3)c 79.6 (51.7)c 69.8 66.8 84.7 77.6
MIR Phasing
Risoe (%) — — 17.1 31.2 15.4 15.2
Phasing powerf — — 1.8 2.0 1.0 0.9
Rcullisg (%) — — 0.55 0.50 0.81 0.84
Overall FOMh 0.60
Refinement
Unliganded FGFR1K:550 residues, 252 water molecules (4589 atoms)
FGFR1K:AMP-PCP: 550 residues, 248 water molecules, 2 AMP-PCP molecules (4646 atoms)
rmsd
Model d-Spacings (A˚) Reflections (N) R-valuei (%) bonds (A˚) angles (0) B-valuesj (A˚2)
Unliganded 6.0–2.0 42548 21.3 (26.2)k 0.008 1.3 1.6
AMP-PCP 6.0–2.3 26729 20.0 (27.0)k 0.008 1.4 1.7
a Thi-1, Thi2: ethylmercurithiosalicylic acid (thimerosal); PCMB: 4-chloromercuribenzoic acid.
b Rsym 5 100 3 ShS i | Ii(h) 2 kI(h)l | / ShSi Ii(h)
c Value in parentheses is for the highest resolution shell.
d I(1h) and I(2h) processed as independent reflections. Anomalous scattering contributions were included.
e Riso 5 100 3 Sh | |Fp(h)| 2 |FPH(h)| | / Sh |FP(h)|, where FP and FPH are the native and derivative structure factors, respectively. All phasing
statistics are for data from 20.0 to 2.8 A˚.
f Phasing power: rms heavy atom structure factor/rms lack of closure (for acentric reflections).
g Rcullis 5 100 3 Sh | | FPH(h) 6 FP(h) | 2 FH(calc)(h) | / Sh | FPH(h) 6 FP(h) | (for centric reflections).
h Figure of merit: e P(F)exp(iF)dF / e P(F)dF, where P is the probability distribution of the phase angle F.
i R-value 5 100 3 Sh | |Fo(h)| 2 |Fc(h)| | / Sh |Fo(h)|, where Fo and Fc are the observed and calculated structure factors, respectively
(Fo . 2s).
j For bonded protein atoms.
k Value in parentheses is the free R-value determined from 5% of the data.
in the IRK structure. Relative to closed-form ternary (Asp-623 in FGFR1K) that serves as the catalytic base
in the phosphotransfer reaction. The catalytic loop se-cAPK (with ATP and an inhibitor peptide bound; Zheng
et al.,1993), the lobe rotation inFGFR1K is z208. Despite quences of FGFR1K and IRK are identical—HRDLA
ARN—and in common with most receptor and nonre-having a different set of crystal lattice contacts, the two
FGFR1K molecules in the asymmetric unit have only a ceptor PTKs. A superposition of the catalytic loops of
FGFR1K (621–628) and IRK (1130–1137) reveals a high28 difference in relative lobe orientation, suggesting that
the z98 difference observed between FGFR1K and IRK degree of structural similarity, with an rmsd for all atoms
of only 0.2 A˚ (Figure 5B). The largest difference (0.6 A˚)is not due merely to crystal packing. In IRK, the lobes are
held open by steric interactions between the nucleotide- is found in the side-chain conformation of Asp-623 and
probably arises from the lack of coordination of Asp-binding loop and residues of the protein kinase-con-
served DFG sequence at the beginning of the activation 623 to a tyrosine substrate (see below).
A striking feature of the unphosphorylated IRK struc-loop, the segment between b8 and aEF. In contrast,
steric interactions between residues in aC and the DFG ture is the presence of Tyr-1162 in the active site of the
enzyme, hydrogen-bonded to Asp-1132, the catalyticmotif account for the open conformation of FGFR1K, in a
manner somewhat similar to that observed for mitogen- base. Tyr-1162 is one of threetyrosine autophosphoryla-
activated protein kinase (MAPK; Zhang et al., 1994). For tion sites in the activation loop. The hydroxyl group of
FGFR1K and IRK, addition of Mg-ATP is sufficient for Tyr-1162 is presumably in position for phosphotransfer,
autophosphorylation to proceed, indicating that the un- yet the ATP binding site appears to be blocked by the
phosphorylated kinase can adopt a closed lobe confor- DFG residues, precluding cis-autophosphorylation of
mation. Tyr-1162. Since FGFR1K has two autophosphorylation
sites conserved in all known FGF receptors, Tyr-653 and
Tyr-654, corresponding to Tyr-1162 and Tyr-1163 of IRKActive Site and AMP–PCP Binding
The catalytic loop of a protein kinase lies between aE (Figure 3), it was anticipated that Tyr-653 of unphosphor-
ylated FGFR1K would similarly be bound in the activeand b7 and contains an invariant aspartic acid residue
Cell
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Figure 2. Overall Views of FGFR1K Structure
(A) Ribbon diagram of the FGFR1K structure. The a helices are shown in red, the b strands in green, the nucleotide-binding loop in orange,
the catalytic loop in blue, the activation loop in yellow, the kinase insert in black, and the side chains of Tyr-653 and Tyr-654 in purple. The
termini are denoted by N and C. Due to disorder, a break appears in the chain between b2 and b3. For this figure and others, the kinase
insert from the C2-B crystal structure (see Experimental Procedures) has been “grafted” onto the C2-A structure described in this paper.
(B) Stereo view of a Ca trace of FGFR1K in the same orientation as in (A). Every tenth residue is marked with an open circle and every twentieth
residue is labeled with the residue number.
(A) prepared with RIBBONS (Carson, 1991); (B), with MOLSCRIPT (Kraulis, 1991).
site. What is observed, however, is that the active sites nucleotide-binding loops. A structure of ATP-bound
of the two FGFR1K molecules in the asymmetric unit FGFR1K (data not shown), obtained from crystals
are unoccupied. soaked in Mg-ATP, is essentially indistinguishable from
Although the activation loops of FGFR1K and IRK are the structure with AMP–PCP.
the same length and are >50% identical in sequence The adenine ring of AMP–PCP makes contacts similar
(Figure 3), the paths of the polypeptide chains are mark- to those observed in the ternary cAPK structure (Bos-
edly dissimilar, diverging at Ala-640 (Gly-1149) and re- semeyer et al., 1993; Zheng et al., 1993). Hydrogen
converging at Val-664 (Val-1173) (Figures 4B and 5A). bonds are present between N1 and the amide nitrogen
Although not highly ordered, Tyr-653 and Tyr-654 are of Ala-564 and between N6 and the carbonyl oxygen of
observed to point away from the active site. The side Glu-562 (Figure 5C). The adenine ring is flanked on one
chain of Tyr-653 is in van der Waals contact with several side by Leu-484 and Val-492 (N-terminal lobe) and on
hydrophobic residues (Val-664, Leu-672, and Phe-710) the otherside by Leu-630 (C-terminal lobe). In the ternary
and is hydrogen-bonded to a backbone carbonyl oxy- cAPK structure, the hydroxyl groups of the ribose moiety
gen (Leu-672O). Tyr-654 is more solvent exposed than of ATP are hydrogen-bonded to residues in the C-termi-
Tyr-653, and its only van der Waals contact is with Val- nal lobe. In contrast, the ribose hydroxyl groups make
706. Many of the residues in the FGFR1K activation loop no direct hydrogen bonds with protein atoms in the
have high temperature values, some exceeding 60 A˚2 binary FGFR1K structure. There is reasonable electron
(average protein B-value is 35 A˚2), implying that this
density for the a and b phosphates of AMP–PCP, but the
loop is relatively mobile. In fact, in one of the FGFR1K
g-phosphate is disordered. No unambiguous electron
molecules, two short segments of the activation loop
density for Mg ions is seen near the phosphates. Thus,
just before and after the tyrosines have not been mod-
there are relatively few interactions observed betweeneled due to disorder.
AMP–PCP and unphosphorylated FGFR1K.The DFG residues in unphosphorylated FGFR1K fol-
low a course more similar to those in cAPK than to
those in IRK, leaving the ATP binding site open. Indeed,
Autoinhibitioncocrystals of FGFR1K and AMP–PCP could be obtained
The structure of unphosphorylated IRK suggested anunder the same conditions as the unliganded FGFR1K
autoinhibition mechanism whereby the sites for bothcrystals and are isomorphous to them. There are no
substrate peptide and ATP are blocked by residues ofsignificant changes in the structure of FGFR1K induced
the activation loop (Hubbard et al., 1994). Stimulationby AMP–PCPbinding. In particular, binding of AMP–PCP
of kinase activity by autophosphorylation is believed to(and by extension ATP) does not by itself promote lobe
result in large part from stabilization of the activationclosure, at least not under the particular crystallization
loop in a noninhibiting conformation, via phosphotyro-conditions used, nor does binding result in any notice-
able changes in the conformations of the activation and sine interactions with positively charged residues. The
Structure of the FGFR1 Tyrosine Kinase Domain
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Figure 3. Structure-Based Sequence Alignment of FGFR1K and IRK
Structure-based sequence alignment of FGFR1K and IRK, including the sequences for human FGFR1–4, for a D. melanogaster homolog
(DFGFR1), and for a C. elegans homolog (EGL-15). The secondary structure assignments for FGFR1K and IRK were obtained using the Kabsch
and Sander algorithm (Kabsch and Sander, 1983) as implemented in PROCHECK (Laskowski et al., 1993). In the FGF receptor sequences, a
period represents sequence identity to FGFR1. In the IRK sequence, residues that are identical to FGFR1 are shaded. A hyphen denotes an
insertion. The numbers under the EGL-15 sequence represent the fractional solvent accessibility (FSA) of the residue in the FGFR1K structure.
The FSA is the ratio of the solvent-accessible surface area of a residue in a Gly-X-Gly tripeptide to that in the FGFR1K structure. A value of
0 represents an FSA between 0.00 and 0.09, 1 represents an FSA between 0.10 and 0.19, etc. The higher the value, the more solvent-exposed
the residue. An asterisk or pound sign in the FSA line indicates that, due to disorder, either the whole residue or just the side chain, respectively,
is not included in the atomic model. The values below the FSA line are the FSAs calculated for the residues in the interface of the dimer
shown in Figure 7.
FGFR1K and IRK activation loops reconverge one resi- of a substrate peptide (Figure 5B). The pyrrolidine ring
of Pro-663 appears to interfere with the binding of adue after PTK-invariant Pro-663 (Pro-1172). The main-
chain dihedral angle c of this proline differs by z908 in substrate tyrosine, since the distance from the ring to
the side chain of superimposed Tyr-1162 (P residue) isthe two structures, and the residues immediately pre-
ceding Pro-663 are inmuch different positions than their only 1.5 A˚ (Pro-663Cg...Tyr-1162Cg), and the distance
from the ring to the main chain of Tyr-1162 is only 1.2 A˚counterparts in IRK (Figures 5A and 5B). Although in the
FGFR1K structure the tyrosines of the FGFR1K activa- (Pro-663Cd...Tyr-1162N). In contrast, Pro-1172 in the
IRK structure is positioned to help orient the phenoliction loop do not block access to the active site, the
C-terminalend of the activation loop appears to interfere ring of a substrate tyrosine; the closest distance be-
tween atoms in the rings of Tyr-1162 and Pro-1172 iswith substrate peptide binding, revealing a second, dis-
tinct mechanism by which receptor PTKs maybe autoin- 3.7 A˚. Furthermore, the side chain of Arg-661 lies very
near to the side chain of superimposed Asp-1161 (P21hibited.
Based on the specific interactions seen in the IRK residue), with a distance of only 0.8 A˚ between main-
chain atoms (Arg-661O...Asp-1161N) and 1.1 A˚ betweenstructure, Tyr-1162 and the residues on either side, Asp-
1161 and Tyr-1163, are presumed to mimic the positions side-chains atoms (Arg-661Cb...Asp-1161Od1). Pro-663
is reasonably well ordered with an average B-value ofof residues in a substrate peptide (P, P21, and P11
residues, respectively). This presumption has been veri- 36 A˚2, while Arg-661 is less ordered with an average B-
value of 49 A˚2. The configurations of Pro-663 and Arg-fied by a structure of phosphorylated IRK complexed
with a substrate peptide (S. R. H., unpublished data). 661 are the same in the two FGFR1K molecules in the
asymmetric unit.When the catalytic loops of FGFR1K and IRK (unphos-
phorylated) are superimposed, Arg-661 and PTK-invari- There are relatively few interactions that stabilize the
activation loop of FGFR1K in the inhibiting conformationant Pro-663 of FGFR1K are positioned to hinder binding
Cell
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Val-706 at the beginning of aG caps this hydrophobic
pocket, whereas an asparagine (Asn-1215) is present at
this position in IRK. Hydrophobicity is conserved at this
position in the FGF receptor subfamily, but is not gener-
ally conserved in the PTK family. Upon autophosphory-
lation of the activation loop tyrosines, Leu-662 and Pro-
663 will likely be in positions corresponding to those of
Leu-1171 and Pro-1172 in IRK.
In the FGFR1K structure, the side chain of Arg-661 is
fully extended and hydrogen-bonded to the carbonyl
oxygen of Gly-697 between aF and aG and to a well-
ordered water molecule. A survey of the PTK family
reveals that at this position an arginine or lysine predom-
inates, most often a lysine. Only an arginine is long
enough to make this hydrogen bond in the FGFR1K
structure, yet a lysine could presumably substitute with
relatively small, commensurate shifts in backbone posi-
tions. Alternatively, arginine or lysine could be semi-
conserved at this position because of interactions this
residue makes in the phosphorylated, activated form of
the kinase. The autoinhibition mechanism suggested by
the FGFR1K structure is likely to be a general feature
of FGF receptors. The relevance of this mechanism for
other receptor tyrosine kinases is at present difficult to
predict.
The crystal structures of a number of PSKs have re-
vealed several different autoinhibition mechanisms (re-
viewed by Johnson et al., 1996). Hindrance to substrate
peptide and/or ATP binding is provided by activation
loop residues or residues C-terminal to the kinase do-
main. One general way inwhich the autoinhibition mech-
anism suggested by the FGFR1K structure differs from
the mechanisms employed by PSKs is that an invariant
PTK residue, Pro-663, appears to play a key role inFigure 4. Superposition of the N- and C-terminal Lobes of FGFR1K
the inhibition, whereas the residues involved in PSKand IRK
autoinhibition are not conserved across the PSK family.(A) Ribbon diagram of the N-terminal lobes of FGFR1K and IRK in
which the Ca atoms of the b sheets have been superimposed.
FGFR1K is colored green and IRK is colored orange. Also shown
Tyrosine Autophosphorylation Sitesare the positions of protein kinase-conserved residues Lys-514 and
Glu-531 (Lys-1030 and Glu-1047 in IRK), which in FGFR1K form a In addition to the two tyrosine autophosphorylation sites
salt bridge, represented by a black line. Carbon atoms are colored in the activation loop (Tyr-653 and Tyr-654), there are
either green (FGFR1K) or orange (IRK); nitrogen atoms, blue; and four other autophosphorylation sites that are present in
oxygen atoms, red. The view is looking up from the C-terminal lobe
the expressed FGFR1K protein (Mohammadi et al.,into the N-terminal lobe, z908 from the view in Figure 2A.
1996): one in the juxtamembrane region (Tyr-463), two(B) Ribbon diagram of the C-terminal lobes of FGFR1K and IRK in
in the kinase insert between aD and aE (Tyr-583 andwhich the Ca atoms of the a helices have been superimposed.
FGFR1K is colored green and IRK is colored orange. The activation Tyr-585), and one in the core of the C-terminal lobe (Tyr-
loops of FGFR1K and IRK are colored blue and red, respectively. 730). These sites show varying degrees of conservation
Included are the tyrosine autophosphorylation sites Tyr-1162 and in mammalian FGF receptors: Tyr-463 and Tyr-585 are
Tyr-1163 in IRK (Tyr-1158 not shown) and Tyr-653 and Tyr-654 in
found in FGFR1–2, Tyr-583 in FGFR1–3, and Tyr-730 inFGFR1K and the catalytic base Asp-1132 in IRK. The hydrogen bond
FGFR1–4 (Figure 3).between Asp-1132 and Tyr-1162 is shown as a black line. The view
The positions of the autophosphorylation sites areis approximately the same as in Figure 2A.
(A) and (B) prepared with RIBBONS. shown in Figure 6A. Tyr-463 is disordered in one of the
FGFR1K molecules and forms a lattice contact in the
other molecule. The kinase insert in FGFR1K is 14 resi-
dues long (relative to Src), six residues longer than inobserved. The residue just before Pro-663, Leu-662, is
in a different hydrophobic site than is Leu-1171 in IRK IRK. This region is disordered in both FGFR1Kmolecules
in the C2 crystal structure described in this report. In(Figure 5B). From a comparison of the FGFR1K and IRK
structures at this location, only one potentially relevant a closely related crystal form (C2-B; see Experimental
Procedures), several lattice contacts partially pin downdifference in residue composition is found. In FGFR1K,
(Figure 5 legend continued)
(C) AMP–PCP interactions. Colors are the same as in Figure 4A except carbon atoms of AMP–PCP are colored orange and phosphorus atoms
are purple. The g-phosphate group is disordered and therefore not shown. The backbone representation of FGFR1K is semitransparent.
Selected hydrogen bonds are shown as black lines. The view is approximately the same as in Figure 2A.
(A) and (C) prepared with GRASP (Nicholls et al., 1991); (B), with RIBBONS.
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Figure 5. Active Site and AMP-PCP Binding
(A) Molecular surface representation of FGFR1K and IRK showing the difference in conformation of the activation loop (green). The catalytic
loop is shown in orange. Coloring of the side-chain atoms is the same as in Figure 4A except carbon atoms are white. The view is z908 from
that in Figure 2A, looking from the right side.
(B) Stereo view of the active sites of FGFR1K and IRK. The Ca atoms of the catalytic loops have been superimposed. Colors are the same
as in Figure 4A. Selected hydrogen bonds are shown as black lines. The view is approximately the same as in Figure 2A.
(Figure 5 legend continued on previous page)
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receptor dimerization is critical for the initiation of auto-
phosphorylation events.
FGF Receptor Kinase Mutations
in Developmental Defects
Several mutations that impair migration of sex my-
oblasts in C. elegans have been identified in EGL-15,
an FGF receptor homolog (DeVore et al., 1995). These
mutations are mapped onto the FGFR1K structure in
Figure 6B. One of the mutations results in an Opal stop
codon at Trp-930 (Arg-756 in FGFR1). This is a tempera-
ture-sensitive mutation that, based on the FGFR1K
structure, would result in the premature termination of
the cytoplasmic domain in the middle of aI. A point
mutation that results in a Glu-680→Lys substitution (Glu-
522 in FGFR1) was also identified. In the FGFR1K struc-
ture, Glu-522 is solvent-exposed and poorly ordered. A
Pro-714→Leu substitution (Pro-556 in FGFR1) in EGL-
15 also leads to a cell signaling defect in C. elegans.
This proline is semiconserved in the PTK family, found
in the insulin, FGF, and PDGF receptors as well as in
Src and Abl. In the FGFR1K structure, the side chain of
Arg-475 is hydrogen-bonded to the carbonyl oxygen
of Pro-556. This hydrogen-bonding interaction is also
observed in the IRK structure, although the proline con-
figuration is different—cis in IRK, trans in FGFR1K. Thus
for many PTKs, the arginine–proline interaction would
appear to play an important role in stabilization of the
N-terminal lobe.
A number of mutations in the kinase domain of FGFR3
have been implicated in various forms of human skeletal
dysplasia. In several cases of thanatophoric dysplasia,
a single base change in the FGFR3 gene leads to a Lys-
Figure 6. Autophosphorylation and Mutation Sites 650→Glu substitution (Lys-656 in FGFR1) in the activa-
(A) The positions of the tyrosine autophosphorylation sites of tion loop of the kinase (Tavormina et al., 1995). This has
FGFR1K are mapped onto a backbone representation (semitrans- recently been shown to be a gain-of-function mutation
parent) of FGFR1K. The view is approximately the same as in Fig-
in which the receptor is partially activated in theabsenceure 2A.
of ligand (Naski et al., 1996). Presumably, the glutamate(B) The sites of mutations in C. elegans EGL-15 and human FGFR3
is involved in stabilizing a noninhibiting conformation ofthat lead to developmental disorders are mapped onto FGFR1K.
The side chains of the corresponding FGFR1 residues are shown. the activation loop. A mutation that results in an Asn-
The EGL-15 Trp-930→Opal substitution results in truncation of the 540→Lys substitution (Asn-546 in FGFR1) has been
cytoplasmic domain in aI. The corresponding residues in FGFR1K identified in a number of patients with hypochon-
that would be deleted are represented in red.
droplasia (Bellus et al., 1995). Asparagine is conserved(A) and (B) prepared with GRASP.
at this position in the mammalian FGF receptors. In the
FGFR1K structure, the side chain of Asn-546 is hydro-
this region inone of the two FGFR1Kmolecules, allowing
gen-bonded to the main-chain of His-541. The Asn-
a trace of the polypeptide chain. Tyr-730 is situated in
540→Lys substitution may also be gain-of-function,
aH in the C-terminal lobe. In the FGFR1K structure, Tyr-
which would suggest that the Asn-546 interactions ob-
730, Met-732, and Met-733 are buried, which implies
served in the FGFR1K structure are inhibitory.
that if Tyr-730 is indeed a bona fide in vivo autophosph-
orylation site, unfolding of aH would be required.
Dimeric FormsThe crystallographic data show that aside from Tyr-
Upon juxtaposition of the extracellular domains of a re-730, the five other autophosphorylation sites are found
ceptor PTK via ligand binding, the cytoplasmic domainsin relatively flexible segments of FGFR1K, as would be
may associate only transiently or form a quasi-stable,expected. Moreover, the spatial positioning of the sites
2-fold-related dimer. Transient association would allowrelative to the active site strongly suggests that auto-
one cytoplasmic domain to act as enzyme and substratephosphorylation occurs by a trans mechanism (between
for the other, and each activated kinase would phos-two kinase domains). Although Tyr-653 and Tyr-654 are
phorylate substrates independently. In this case, kinasenear enough to the active site to be autophosphorylated
activation is achieved solely from trans-autophosphory-in cis, kinetic data are consistent with trans-autopho-
lation made possible by the increased local concentra-sphorylation of these two tyrosines (data not shown).
tion of substrate (the receptor itself), which dimerizationThus, the FGFR1K structure provides additional evi-
dence to support the working model that ligand-induced of the extracellular domains provides. Alternatively, the
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is arguably too stringent for cytoplasmic domains that
are tethered to the membrane (reducing the effective
dimensionality) and brought within close proximity by
extracellular binding events. Thus, the biological rele-
vance of the dimers observed in the crystal structure
remains to be determined.
Conclusions
The crystal structure of FGFR1K provides us with a sec-
ond three-dimensional structure of a receptor PTK do-
main. The most significant difference between the struc-
tures of FGFR1K and IRK is the conformation of theFigure 7. FGFR1K Dimer
activation loop. In FGFR1K, the activation loop is dis-
View of one of the crystallographically related dimers of FGFR1K.
posed such that the binding site for substrate peptidesColoring same as in 2A. The 2-fold axis is running vertically in the
is blocked not by an activation loop tyrosine, as in IRK,plane of the figure. Prepared with RIBBONS.
but by Arg-661 and PTK-invariant Pro-663, while the
ATP binding site is accessible. This represents anotherformation of a cytoplasmic dimer could lead to kinase
molecular mechanism by which a receptor PTK may beactivation if, for example, a rearrangement of the activa-
autoinhibited. The observed autoinhibition in FGFR1Ktion loop is stabilized by interactions within the dimer.
would appear to be weaker than that in IRK becauseOwing to physical constraints, autophosphorylation
of fewer specific interactions made by residues in thewould presumably occur between dimers rather than
FGFR1K activation loop (manifested in the relativelywithin a dimer. This would require that higher-order re-
higher B-values) and the accessibility of the ATP site.ceptor oligomerization occur, if only transiently. For FGF
One obvious distinction between the insulin and FGFreceptors, higher-order oligomerization states may be
receptor families is that in the former, receptors areinduced by multivalent heparin/FGF complexes (Schles-
covalently linked heterotetramers (a2b2), whereas in thesinger et al., 1995).
latter, receptor dimerization is ligand dependent. Recep-The above activation scenarios led us to consider the
tors whose kinase domains are always inclose proximitypotential biological significance of three 2-fold-related
may require a stronger autoinhibition mechanism thanFGFR1K dimers observed in the crystal structure, one
those receptors that associate only upon ligand binding,noncrystallographic and two crystallographic. The non-
as has been suggested (Taylor et al., 1995). Since mostcrystallographic dimer comprises the two molecules in
growth factor receptors undergo ligand-dependent di-the asymmetric unit. In this dimer, the C-terminal lobes
merization and activation, the FGF receptor autoinhibi-abut with the N-terminal lobes distal to one another.
tion mechanism may be a more general one.The total accessible surface area buried in the interface
How do autoinhibited PTK domains trans-autophos-is z950 A˚2, a relatively low value for protein–protein
phorylate? It is clear from the B-values for the residuesinteractions of biological relevance (Janin and Chothia,
in the FGFR1K activation loop that segments of this1990). For one of the crystallographically related dimers,
loop are relatively mobile, and therefore an equilibriumboth hydrophobic and electrostatic interactions are
between different conformations of the activation looppresent in the interface, yet the total surface area buried
is likely to exist. A majority of these conformations willis only z670 A˚2. The other crystallographic dimer buries
be inhibiting—slight variations of the conformation seena comparatively large z1650 A˚2 in its interface. In this
in the FGFR1K crystal structure—yet some will permitdimer, the C helices of the two protomers are nearly
binding of substrate peptide, and in fact, the presenceparallel and contact each other at their C-terminal ends
of substrate peptide will alter this equilibrium. Upon(Figure 7). The changes in accessible surface area per
ligand binding, the local substrate (receptor) concentra-residue upon dimer formation are shown in Figure 3.
The N-termini of this dimer point in the same direction tion is substantially increased through receptor oligo-
and are within 30 A˚ of one another; the two polypeptide merization, enhancing the probability of a transient,
chains of an actual cytoplasmic dimer would be ex- trans-autophosphorylation event. A balance may be
pected to converge at the membrane. Interestingly, a struck toprovide inhibition strong enough to deter phos-
mutation in C. elegans EGL-15 has been identified that phorylation of substrates in the absence of the extracel-
suppresses the temperature-sensitive phenotype due lular signal, yet weak enough to allow trans-autophos-
to the Trp-930→Opal substitution mentioned above. The phorylation via receptor oligomerization once the
suppressor mutation results in the substitution Thr- extracellular signal has arrived.
692→Ile (DeVore and Stern, unpublished data). The
equivalent position in FGFR1 is Met-534, which is in the Experimental Procedures
dimer interface.
Expression and Purification of FGFR1KThere are no obvious structural differences between
A recombinant baculovirus was engineered to encode residues 456–the two FGFR1K molecules in the asymmetric unit, only
765 of human FGFR1. A cleavable N-terminal histidine tag was incor-one of which forms the dimer related by crystallographic
porated to aid in protein purification. Three amino acid substitutions
symmetry, that would suggest that one molecule is more were introduced: Cys-488→Ala, Cys-584→Ser, and Leu-457→Val.
“activated” than the other. In preliminary experiments, The two cysteine substitutions were made to prevent the formation
we have not detected dimer formation in solution, al- of disulfide-linked oligomers, which occurs for the native protein.
The substitution Leu-457→Val was necessary to introduce a NcoIthough thecriterion of observing dimerization in solution
Cell
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cloning site near Met-456. The codon for Tyr-766 (TAC) was changed R-value of 30.4%) with rmsd values of 0.008 A˚ for bond distances
and 1.48 for bond angles.to a stop codon (TAG) and a HindIII-cloning site was generated
following this stop codon. These substitutions were introduced into Molecular replacement was used to locate the two FGFR1K mole-
cules in the asymmetric unit of the C2-A crystal form. Using AMOREthe full-length human cDNA of FGFR1 in m13MP19 by site-directed
mutagenesis according to the manufacturer’s protocol (Amersham). and the C2-B structure as a search model, the c.c. for the correct
2-molecule solution was 0.62 (versus 0.35 for the highest incorrectThe resulting construct was digested with NcoI and HindIII and was
ligated into appropriately digested pBlueBac HistagB (Invitrogen). solution). Heavy atom positions were determined from difference
Fourier maps using the calculated phases from the partial model.Transfection of insect cells, identification of positive plaques, and
protein purification were performed as described (Mohammadi et Refinement of heavy atom parameters and phase determination
were performed with MLPHARE (Otwinowski, 1991). An MIR-phasedal., 1996). Five amino acids remained from the histidine tag. The
predicted molecular mass was confirmed by mass spectrometry. electron density map was calculated with data between 20.0 and
2.8 A˚ resolution and was improved by solvent flattening, histogram
matching, and noncrystallographic symmetry (NCS) averaging usingCrystallization and Data Collection
DM (Cowtan, 1994).Purified FGFR1K was concentrated to 20–50 mg/ml and exchanged
Refinement of the C2-A unliganded FGFR1K structure againstinto 10 mM Tris–HCl (pH 8.0), 10 mM NaCl, and 2 mM DTT using a
6.0–2.0 A˚ data (Native in Table 1) proceeded by conjugate-gradientCentricon-30 (Amicon). Crystals were grown at 48C by vapor diffu-
minimization and simulated annealing using X-PLOR. Tight NCSsion in hanging drops containing 2.0 ml of 10 mg/ml protein solution
restraints were imposed until data to 2.0 A˚ resolution were includedand 2.0 ml of reservoir solution: 16% polyethylene glycol (PEG)
in the refinement, at which point the restraints were lifted. An overall10000, 0.3 M (NH4)2SO4, 5% ethylene glycol, and 100 mM bis-Tris
anisotropic B-value was calculated using X-PLOR and applied to(pH 6.5). The crystals belong to monoclinic space group C2 and
the observed structure factors, reducing the R-value by z3%. Waterhave unit cell dimensions of a 5 208.3 A˚, b 5 57.8 A˚, c 5 65.6 A˚,
molecules whose B-values refined to $70 A˚2 were omitted from theb 5 107.28 when frozen (C2-A). When crystals were grown in the
subsequent refinement round. The average B-value is 37.5 A˚2 for allpresence of 5% glycerol instead of ethylene glycol, a slightly differ-
protein atoms, 35.4 A˚2 for protein atoms in FGFR1K-A, 39.7 A˚2 forent C2 crystal form was obtained, with unit cell dimensions of a 5
protein atoms in FGFR1K-B, and 40.2 A˚2 for water molecules. The211.6 A˚, b 5 51.3 A˚, c 5 66.1 A˚, b 5 107.78 (C2-B). Crystals typically
side chains for Cys-603 in FGFR1K-A and FGFR1K-B and for Met-grew to 0.6 3 0.3 3 0.2 mm in 3–4 weeks. There are two molecules
534 in FGFR1K-B have been modeled in two different conforma-in the asymmetric unit (FGFR1K-A and FGFR1K-B) and the solvent
tions. Residues that are not included in the atomic model due to poorcontent is 55% for C2-A and 50% for C2-B (assuming 0.73 cm3/
supporting electron density are for FGFR1K-A: 456–463, 486–490,gm). Crystals of FGFR1K complexed with AMP–PCP were obtained
501–504, 580–591, 763–765; and for FLG-B: 456–460, 501–504, 578–as above except that the protein solution contained 10 mM AMP–
593, 646–651, 657–659, 762–765.PCP and 20 mM MgCl2.
Atomic superpositions were performed with TOSS (Hendrickson,Data were collected either on a Rigaku RU-200 rotating anode
1979). Per residue solvent accessible surface calculations were(Cu Ka) operated at 50 kV and 100 mA and equipped with double-
done with X-PLOR, and buried accessible surface areas were calcu-focusingmirrors and an R-AXIS IIC image plate detector, or at beam-
lated (with water molecules excluded) with GRASP (Nicholls et al.,line X-4A at the National Synchrotron Light Source, Brookhaven
1991); a probe radius of 1.4 A˚ was used. As defined in PROCHECKNational Laboratory. Synchrotron data (l 5 1.07 A˚) were collected
(Laskowski et al., 1993), 93% of the residues in the model haveon Fuji image plates and digitized with a Fuji scanner. One cryo-
main-chain torsion angles in the most favored Ramachandran re-cooled crystal was used for each of the data sets. Crystals were
gions. There are no residues in disallowed regions and three resi-soaked in a cryo-protectant containing 25% PEG 10000, 0.3 M
dues in generously allowed regions.(NH4)2SO4, 5% ethylene glycol or glycerol, and 100 mM bis-Tris (pH
6.5), and were flash-cooled either in liquid nitrogen directly (synchro-
tron) or in a dry nitrogen stream at 21758C (rotating anode). All data Acknowledgments
were processed using DENZO and SCALEPACK(Otwinowski, 1993).
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